Office of Health Disparities Research

Addressing Health Disparities is Our Priority.

November 16, 2018

Sex and Gender in Alzheimer’s Disease–Does it Matter?

By Sumedha Penheiter

In a recently published article, Mayo clinician researcher Michelle Mielke, PhD, discusses issues surrounding the benefits and drawbacks of studying sex and gender differences in the etiology, diagnosis, treatment, and outcomes of Alzheimer’s Disease at all levels, including basic science studies, clinical research, and clinical trials.  She and her co-authors take on the long-standing question of whether the modest understandings gained from studying sex differences in the disease, where, in the U.S., the incidence of AD dementia does not significantly differ between men and women, outweigh the research burdens of doubling the participant pool, lengthening the time of studies, and increasing costs.  ARTICLE

 

Tags: Mayo Clinic, News, news

Please login or register to post a reply.
Contact Us · Privacy Policy